Neurology Archives - Page 8 of 11

Literature review and economic evaluation of oral and intramuscular ziprasidone treatment among patients with schizophrenia in China

Authors: Y C Yeh, X Yu, C Zhang, W Hao, F Du, D Liu, L Yang, X Gao Published: General Psychiatry, 2019 View publication Background Over 10 million Chinese are affected by schizophrenia....

Cost-effectiveness of teriflunomide compared to interferon beta-1b for relapsing multiple sclerosis patients in China

Authors: Y Xu, N Mao, V Chirikov, F Du, Y C Yeh, L Liu, X Gao Published: Clinical Drug Investigation, 2019 View publication Background and Objective Teriflunomide is a once-daily oral immunomodulatory...

Impact of medical marijuana legalization on opioid use, chronic opioid use, and high-risk opioid use

Authors: A Shah, C J Hayes, M Lakkad, B C Martin Published: Journal of General Internal Medicine, 2019 View publication Objective To determine the association of medical marijuana legalization with prescription opioid...

Cost-effectiveness of alemtuzumab in the treatment of relapsing forms of multiple sclerosis in the United States

Authors: V Chirikov, I Ma, N Joshi, D Patel, A Smith, C Giambrone, N Cornelio, L Hashemi Published: Value in Health, 2018 View publication Objective To evaluate the cost-effectiveness of alemtuzumab compared...

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

Authors: M Treur, B Heeg, H J Möller, A Schmeding, B van Hout Published: BMC Health Services Research, 2010 View publication Background As schizophrenia patients are typically suspicious of, or are hostile...

Prevalence and incidence of severe sepsis in Dutch intensive care units

Authors: A van Gestel, J Bakker, CP Veraart, BA van Hout. Published: Critical Care, 2010 View publication Objective Severe sepsis is a dreaded consequence of infection and necessitates intensive care treatment. Severe...

Modelling the treated course of schizophrenia: development of a discrete event simulation model

Authors: B Heeg, E Buskens, M Knapp, G van Aalst, PJ Dries, L de Haan, BA van Hout. Published: PharmacoEconomics, 2010 View publication Abstract In schizophrenia, modelling techniques may be needed to...

Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model

Authors: M F Botteman, R J Ozminkowski, S Wang, C L Pashos, K Schaefer, D J Foley Published: CNS Drugs, 2010 View publication Objective Although the clinical benefits of pharmacological treatments for...

A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia

Authors: K T Carpiuc, J M Stephens, M F Botteman, W Feng, J W Hay Published: Expert Opinion on Pharmacotherapy, 2010 View publication Abstract Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) is...

News